Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of dexmedetomidine on post-CABG atrial fibrillation
IRCT2017021914359N4Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in Atrial fibrillation (AFib), sponsored by Guilan University of Medical Sciences. Started Mar 2017; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on IRCT2017021914359N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017021914359N4.